Titre : Transglutaminases

Transglutaminases : Questions médicales fréquentes

Termes MeSH sélectionnés :

Computer-Aided Design
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Transglutaminases : Questions médicales les plus fréquentes", "headline": "Transglutaminases : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Transglutaminases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-05", "dateModified": "2025-04-30", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Transglutaminases" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Aminoacyltransferases", "url": "https://questionsmedicales.fr/mesh/D019881", "about": { "@type": "MedicalCondition", "name": "Aminoacyltransferases", "code": { "@type": "MedicalCode", "code": "D019881", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.913.050.200" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Protein glutamine gamma glutamyltransferase-2", "alternateName": "Protein Glutamine gamma Glutamyltransferase 2", "url": "https://questionsmedicales.fr/mesh/D000091345", "about": { "@type": "MedicalCondition", "name": "Protein glutamine gamma glutamyltransferase-2", "code": { "@type": "MedicalCode", "code": "D000091345", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.913.050.200.800.650" } } } ], "about": { "@type": "MedicalCondition", "name": "Transglutaminases", "alternateName": "Transglutaminases", "code": { "@type": "MedicalCode", "code": "D011503", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Mari T Kaartinen", "url": "https://questionsmedicales.fr/author/Mari%20T%20Kaartinen", "affiliation": { "@type": "Organization", "name": "Faculty of Medicine (Experimental Medicine), McGill University, Montreal, QC H3A 0J7, Canada." } }, { "@type": "Person", "name": "Jeffrey W Keillor", "url": "https://questionsmedicales.fr/author/Jeffrey%20W%20Keillor", "affiliation": { "@type": "Organization", "name": "Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, ON K1N 6N5, Canada." } }, { "@type": "Person", "name": "Teea Salmi", "url": "https://questionsmedicales.fr/author/Teea%20Salmi", "affiliation": { "@type": "Organization", "name": "School of Medicine, University of Tampere, Tampere, Finland." } }, { "@type": "Person", "name": "Katri Lindfors", "url": "https://questionsmedicales.fr/author/Katri%20Lindfors", "affiliation": { "@type": "Organization", "name": "Pediatric Research Center, University of Tampere and Tampere University Hospital, Finn Medi 3, 33520, Tampere, Finland. katri.lindfors@uta.fi." } }, { "@type": "Person", "name": "Vitaliy Kolotylo", "url": "https://questionsmedicales.fr/author/Vitaliy%20Kolotylo", "affiliation": { "@type": "Organization", "name": "Department of Food Biotechnology and Microbiology, Institute of Food Sciences, Warsaw University of Life Sciences-SGGW, Nowoursynowska 159 C, 02-776 Warsaw, Poland." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Advances of computer-aided drug design (CADD) in the development of anti-Azheimer's-disease drugs.", "datePublished": "2023-06-09", "url": "https://questionsmedicales.fr/article/37302540", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.drudis.2023.103665" } }, { "@type": "ScholarlyArticle", "name": "Computer-Aided Design of DNA Self-Limited Assembly for Relative Quantification of Membrane Proteins.", "datePublished": "2022-06-21", "url": "https://questionsmedicales.fr/article/35726775", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.analchem.2c01909" } }, { "@type": "ScholarlyArticle", "name": "Feasibility of Computer-Aided Design in Limb Lengthening Surgery: Surgical Simulation and Guide Plates.", "datePublished": "2022-08-04", "url": "https://questionsmedicales.fr/article/35924698", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/os.13328" } }, { "@type": "ScholarlyArticle", "name": "Comparison of the Degree of Staining of Computer-Aided Design-Computer-Aided Manufacture (CAD-CAM) Ceramic Veneers by Green Tea, Coffee, and Coca-Cola Using a Digital Spectrophotometer.", "datePublished": "2023-02-07", "url": "https://questionsmedicales.fr/article/36747464", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.12659/MSM.939341" } }, { "@type": "ScholarlyArticle", "name": "A 3-Year Clinical Evaluation of Endodontically Treated Posterior Teeth Restored with Resin Nanoceramic Computer-Aided Design/Computer-Aided Manufacture (CAD/CAM)-Fabricated Partial Crowns.", "datePublished": "2022-08-18", "url": "https://questionsmedicales.fr/article/35978528", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.12659/MSM.937331" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Transferases", "item": "https://questionsmedicales.fr/mesh/D014166" }, { "@type": "ListItem", "position": 5, "name": "Acyltransferases", "item": "https://questionsmedicales.fr/mesh/D000217" }, { "@type": "ListItem", "position": 6, "name": "Aminoacyltransferases", "item": "https://questionsmedicales.fr/mesh/D019881" }, { "@type": "ListItem", "position": 7, "name": "Transglutaminases", "item": "https://questionsmedicales.fr/mesh/D011503" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Transglutaminases - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Transglutaminases", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Transglutaminases", "description": "Comment diagnostiquer une carence en transglutaminases ?\nQuels tests sont utilisés pour évaluer les transglutaminases ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes indiquent un problème de transglutaminases ?\nPeut-on diagnostiquer par imagerie ?", "url": "https://questionsmedicales.fr/mesh/D011503?mesh_terms=Computer-Aided+Design&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Transglutaminases", "description": "Quels sont les symptômes d'une dysfonction des transglutaminases ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes sont-ils immédiats après ingestion ?\nLes symptômes peuvent-ils être confondus avec d'autres maladies ?", "url": "https://questionsmedicales.fr/mesh/D011503?mesh_terms=Computer-Aided+Design&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Transglutaminases", "description": "Comment prévenir les troubles liés aux transglutaminases ?\nLes tests génétiques aident-ils à la prévention ?\nL'éducation nutritionnelle est-elle importante ?\nLes enfants doivent-ils être testés ?\nPeut-on prévenir les symptômes par des changements de mode de vie ?", "url": "https://questionsmedicales.fr/mesh/D011503?mesh_terms=Computer-Aided+Design&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Transglutaminases", "description": "Quel est le traitement principal pour les troubles liés aux transglutaminases ?\nDes médicaments sont-ils nécessaires ?\nLa supplémentation est-elle recommandée ?\nLes traitements sont-ils efficaces ?\nY a-t-il des traitements alternatifs ?", "url": "https://questionsmedicales.fr/mesh/D011503?mesh_terms=Computer-Aided+Design&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Transglutaminases", "description": "Quelles complications peuvent survenir avec des troubles de transglutaminases ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles fréquentes ?\nY a-t-il un risque accru de cancers ?", "url": "https://questionsmedicales.fr/mesh/D011503?mesh_terms=Computer-Aided+Design&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Transglutaminases", "description": "Quels sont les facteurs de risque pour les troubles de transglutaminases ?\nL'âge joue-t-il un rôle dans le risque ?\nLe sexe influence-t-il le risque ?\nLes antécédents médicaux augmentent-ils le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D011503?mesh_terms=Computer-Aided+Design&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une carence en transglutaminases ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic peut être établi par des tests sanguins mesurant les niveaux d'enzymes spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les transglutaminases ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests d'anticorps anti-transglutaminase tissulaire sont couramment utilisés." } }, { "@type": "Question", "name": "Les biopsies sont-elles nécessaires pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une biopsie intestinale peut être nécessaire pour confirmer une maladie cœliaque associée." } }, { "@type": "Question", "name": "Quels symptômes indiquent un problème de transglutaminases ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la diarrhée, la fatigue et les douleurs abdominales peuvent indiquer un problème." } }, { "@type": "Question", "name": "Peut-on diagnostiquer par imagerie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie n'est pas utilisée pour diagnostiquer les problèmes de transglutaminases." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une dysfonction des transglutaminases ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles digestifs, des éruptions cutanées et une fatigue chronique." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier, les enfants présentant souvent des symptômes digestifs plus marqués." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes neurologiques comme des maux de tête peuvent survenir en cas de carence." } }, { "@type": "Question", "name": "Les symptômes sont-ils immédiats après ingestion ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent apparaître plusieurs heures ou jours après l'ingestion d'aliments problématiques." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils être confondus avec d'autres maladies ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être similaires à ceux d'autres troubles digestifs comme le syndrome de l'intestin irritable." } }, { "@type": "Question", "name": "Comment prévenir les troubles liés aux transglutaminases ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par un régime alimentaire sans gluten pour ceux à risque de maladie cœliaque." } }, { "@type": "Question", "name": "Les tests génétiques aident-ils à la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques peuvent identifier les personnes à risque de développer des troubles." } }, { "@type": "Question", "name": "L'éducation nutritionnelle est-elle importante ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'éducation sur les aliments contenant du gluten est cruciale pour la prévention." } }, { "@type": "Question", "name": "Les enfants doivent-ils être testés ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants ayant des antécédents familiaux de maladie cœliaque devraient être testés." } }, { "@type": "Question", "name": "Peut-on prévenir les symptômes par des changements de mode de vie ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des changements de mode de vie, comme une alimentation équilibrée, peuvent aider à prévenir les symptômes." } }, { "@type": "Question", "name": "Quel est le traitement principal pour les troubles liés aux transglutaminases ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal est un régime sans gluten pour les personnes atteintes de maladie cœliaque." } }, { "@type": "Question", "name": "Des médicaments sont-ils nécessaires ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments peuvent être prescrits pour traiter les symptômes, mais pas pour la cause sous-jacente." } }, { "@type": "Question", "name": "La supplémentation est-elle recommandée ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La supplémentation en vitamines et minéraux peut être nécessaire en cas de carences nutritionnelles." } }, { "@type": "Question", "name": "Les traitements sont-ils efficaces ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Un régime strict sans gluten est généralement très efficace pour soulager les symptômes." } }, { "@type": "Question", "name": "Y a-t-il des traitements alternatifs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements alternatifs comme l'acupuncture sont explorés, mais leur efficacité n'est pas prouvée." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des troubles de transglutaminases ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des carences nutritionnelles, des troubles auto-immuns et des cancers intestinaux." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications, comme les carences, peuvent être réversibles avec un traitement approprié." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent gravement affecter la qualité de vie en provoquant des douleurs et des limitations." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont fréquentes chez les personnes non traitées pour la maladie cœliaque." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de cancers ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes atteintes de maladie cœliaque non traitée ont un risque accru de cancers intestinaux." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles de transglutaminases ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et des infections intestinales." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle dans le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque est plus élevé chez les jeunes enfants et les adultes jeunes." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes sont plus souvent diagnostiquées avec des troubles liés aux transglutaminases." } }, { "@type": "Question", "name": "Les antécédents médicaux augmentent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies auto-immunes augmentent le risque de troubles de transglutaminases." } }, { "@type": "Question", "name": "Les facteurs environnementaux jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs comme l'alimentation et les infections peuvent influencer le risque." } } ] } ] }

Sources (10000 au total)

Feasibility of Computer-Aided Design in Limb Lengthening Surgery: Surgical Simulation and Guide Plates.

To evaluate the feasibility and utility of computer-aided design (CAD) in surgical treatment of leg length discrepancy (LLD) using monorail external fixators.... In the present case series, we retrospectively analyzed seven patients diagnosed with LLD who were surgically treated using a monorail external fixator between June 2018 and August 2020. A personalize... The mean limb lengthening achieved was 6.41 ± 2.54 (range, 3.30-10.54) cm with either varus or valgus correction. The mean operative duration was 151 ± 41.87 (84-217) minutes and mean blood loss was 5... Simultaneous length and angular correction can be achieved by incorporating CAD into the surgical treatment of patients with LLD, without compromising postoperative lower limb function. CAD demonstrat...

A 3-Year Clinical Evaluation of Endodontically Treated Posterior Teeth Restored with Resin Nanoceramic Computer-Aided Design/Computer-Aided Manufacture (CAD/CAM)-Fabricated Partial Crowns.

BACKGROUND We aimed to investigate the clinical effects of resin nanoceramic (RNC) computer-aided design/computer-aided manufacture (CAD/CAM) partial crowns on posterior teeth after root canal treatme...

Design and Evaluation of NSAID Derivatives as AKR1C3 Inhibitors for Breast Cancer Treatment through Computer-Aided Drug Design and In Vitro Analysis.

Breast cancer is a major global health issue, causing high incidence and mortality rates as well as psychological stress for patients. Chemotherapy resistance is a common challenge, and the Aldo-keto ...

Insights into the computer-aided drug design and discovery based on anthraquinone scaffold for cancer treatment: A systematic review.

In the search for better anticancer drugs, computer-aided drug design (CADD) techniques play an indispensable role in facilitating the lengthy and costly drug discovery process especially when natural... The conduct and reporting of this review were done in accordance to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) 2020 guideline. The protocol was registered in the "... Databases searching retrieved a total of 317 records. After deduplication and applying the eligibility criteria, the final review ended up with 32 articles in which 3 articles were found by citation s... By harnessing the power of computational tools and leveraging the natural diversity of anthraquinone compounds, researchers can expedite the development of better drugs to address the unmet medical ne...

Influence of the femoral entry point for intramedullary alignment in total knee arthroplasty: A computer-aided design approach.

The aim of this study was to simulate different entry points and investigate potential angulation errors of the intramedullary device and resulting changes in the distal femoral cut using a computer-a... We used a CAD approach to simulate various distal femoral entry points for intramedullary instrumentation. Simulations were performed on (i) a commercially available three-dimensional (3D) CAD model o... The ideal entry point in the FaroFemur was 9.9 mm anterior and 4.3 mm medial to the apex of the intercondylar notch, and 9.2 mm anterior and 3.6 mm medial in the DigitalFemur. A medial entry point inc... Minor deviations of the entry point for intramedullary instrumentation during total knee arthroplasty can result in malalignment of several degrees....